National Institutes of Health (NIH), researchers have identified a novel role for a gene known as heat shock protein 60 (Hsp60), finding that it is critical in tissue regeneration and wound healing. Researchers found that topical treatment of an Hsp60-containing gel dramatically accelerates wound closure in a diabetic mouse model. The study was published online today, October 27, in the journal npj Regenerative Medicine.
For the first time, NIH researchers have demonstrated in mice that gene therapy may be the best method for correcting the single faulty gene that causes Niemann-Pick disease, type C1 (NPC1), a rare and fatal disorder of the central nervous system. The study, led by researchers at the National Human Genome Research Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, was published Oct. 26 in Human Molecular Genetics.
Leslie G. Biesecker, M.D., chief of NHGRI's Medical Genomics and Metabolic Genetics Branch, has been elected to the National Academy of Medicine (NAM). Dr. Biesecker is a clinical and molecular geneticist who studies the cause of rare disorders, such as Proteus syndrome, to improve medical treatment for affected individuals. NAM recognizes individuals who have made major contributions to the advancement of medical science, health care and public health.
In this issue of The Genomics Landscape, we feature an overview of NHGRI's impressive technology development programs and the many accomplishments and goals those programs have achieved. There's also a story on an NHGRI training program that "turns docs into researchers," a review of a recent workshop that focused on family health history tools and a welcome to two new policy and education fellows.
NHGRI is pushing beyond current capabilities in genome sequencing. New funding awards, totaling approximately $6.7 million, are part of a technology investment that began in 2004. The aim is to advance the development of genome sequencing technologies that are faster, cheaper, and more accurate and sensitive than those we already have.